Trial Profile
Alogliptin improve the model-assessed beta-cell function in 52 weeks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Mar 2016 New trial record